Literature DB >> 16170192

Complete remission with imatinib in metastastic gastrointestinal stromal tumors.

Sebastian Bauer, Hauke Lang, Jochen Schütte, Jörg Thomas Hartmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16170192     DOI： 10.1200/JCO.2005.02.1063

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Analysis of a case with disappearance of the primary gastrointestinal stromal tumor and progressive liver metastases under long-term treatment with tyrosine kinase inhibitors.

Authors:  Silke Cameron; Theodoros Savvoukidis; Thomas Armbrust; Florian Haller; Julia Kitz; László Füzesi; Giuliano Ramadori
Journal:  Med Oncol       Date:  2009-03-18       Impact factor: 3.064

2.  Symptomatic hypoglycemia during imatinib mesylate in a non-diabetic female patient with gastrointestinal stromal tumor.

Authors:  M Haap; B Gallwitz; C Thamer; K Müssig; H-U Häring; L Kanz; J T Hartmann
Journal:  J Endocrinol Invest       Date:  2007-09       Impact factor: 4.256

3.  A Novel Medical Treatment of Cushing's Due to Ectopic ACTH in a Patient With Neurofibromatosis Type 1.

Authors:  Gul Bano; Farheen Mir; Nigel Beharry; Philip Wilson; Shirley Hodgson; Stephen Schey
Journal:  Int J Endocrinol Metab       Date:  2012-12-21

Review 4.  Complete response of advanced rectal gastrointestinal stromal tumors after imatinib treatment: A case report and literature review.

Authors:  Tingting Wu; Xiaobin Cheng; Wenbin Chen
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.